PMC:7228307 / 844-1042 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"20","span":{"begin":96,"end":100},"obj":"Gene"}],"attributes":[{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" cytokines or other Igs. The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agoni"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7","span":{"begin":1,"end":10},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":" cytokines or other Igs. The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agoni"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":53,"end":56},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T12","span":{"begin":71,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T13","span":{"begin":96,"end":98},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":" cytokines or other Igs. The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agoni"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"20","span":{"begin":96,"end":100},"obj":"Gene"}],"attributes":[{"id":"A20","pred":"pubann:denotes","subj":"20","obj":"Gene:2213"}],"text":" cytokines or other Igs. The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agoni"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T7","span":{"begin":1,"end":10},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":" cytokines or other Igs. The use of mAb therapeutics has also revealed a “scaffolding” role for FcγR which, in different contexts, may either underpin the therapeutic mAb action such as immune agoni"}